Close
Almac
Achema middle east

Yuvraj

Biogen Idec Receives Positive Opinion from the CHMP and Authorisation from Health Canada on AVONEX PEN

Biogen Idec announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the...

BioSante Pharmaceuticals Announces Pancreatic and Prostate Cancer Vaccine License

BioSante Pharmaceuticals, Inc. announced it has licensed its Pancreas Cancer Vaccine and Prostate Cancer Vaccine to Aduro BioTech, a clinical-stage immunotherapy company, solely for...

Trophos presents data at the American Academy of Neurology on SMA and MS

Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology,...

Joining forces to beat cancer in Asia

Three of the world’s biggest pharma companies are joining forces to try and combat Asia’s ‘cancer epidemic’ The figures are startling: Asia-Pacific makes up...

CIT strengthens services in immunotoxicology

CIT, a leading European CRO specializing in non-clinical health and safety research, is pleased to announce the appointment of a new multi-disciplinary team of...

PharmaDiagnostics’ SoPRano (TM) wins prestigious product award at SBS 2011

PharmaDiagnostics NV, a company developing and marketing a broadly-enabling, label-free screening technology that uniquely does not require specialized equipment, announces today that their SoPRano(TM)...

Sun Pharma and Merck Establish Joint Venture to Develop and Commercialize Novel Formulations and Combinations of Medicines

Merck & Co., Inc., a global health care leader, known as MSD outside the United States and Canada,and Sun Pharmaceutical Industries Ltd., (“Sun...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read

Translate »